Anita Dushyanth

@AnitaDushyanth

Dr. Anita Dushyanth is a Biotechnology and Medical Devices Analyst with Zacks Investment Research.

Vrijeme pridruživanja: svibanj 2014.

Tweetovi

Blokirali ste korisnika/cu @AnitaDushyanth

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AnitaDushyanth

  1. 13. sij

    Zacks SCR on the oncology panel at JPM

    Poništi
  2. proslijedio/la je Tweet
    7. kol 2019.

    very solid Q2 . Revenue dead on with our est., record product margin, opex slightly lower than expected. MannKind Corporation Reports 2019 Second Quarter Financial Results and Recent Business Highlights via

    Poništi
  3. 13. lip 2019.
    Poništi
  4. 5. lip 2019.

    Waiting to hear keynote speaker Jamie Dimon

    Poništi
  5. 4. lip 2019.

    The Gene: an intimate history New York Times bestseller by keynote speaker today at

    Poništi
  6. 11. lis 2018.
    Poništi
  7. 20. ruj 2018.
    Poništi
  8. 29. lip 2018.

    Health-care system faces 'huge strain' from expected spike in cancer cases | CBC News

    Poništi
  9. 22. lip 2018.

    Small-cap stocks set new highs, outpacing their multinational peers via

    Poništi
  10. proslijedio/la je Tweet
    11. lip 2018.

    Final research phase for Global Challenge!

    Poništi
  11. proslijedio/la je Tweet
    16. svi 2018.

    : Q1: FORE-SIGHT Revenue Jumps 20% in Q1. Sensors Sales Accelerating. Moving PT to $4.00/share via

    Poništi
  12. 15. svi 2018.
    Poništi
  13. proslijedio/la je Tweet
    15. tra 2018.
    Poništi
  14. proslijedio/la je Tweet
    3. tra 2018.

    We have added to our coverage universe! Check out our Initiation Report by -

    Poništi
  15. proslijedio/la je Tweet
    7. velj 2018.

    Merging The Brand And Branding The Merger!

    Poništi
  16. proslijedio/la je Tweet
    12. pro 2017.
    Poništi
  17. proslijedio/la je Tweet
    12. pro 2017.
    Poništi
  18. proslijedio/la je Tweet
    5. pro 2017.
    Poništi
  19. proslijedio/la je Tweet
    14. stu 2017.

    Business And Financial Update For Third Quarter 2017

    Poništi
  20. 18. lis 2017.

    Early Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced... via

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·